These results were obtained by in vitro and in vivo studies and were confirmed by analyzing monocytes/macrophages from AD patients; as a matter of fact, the monocytic CB2 and FAAH levels significantly correlated with clinical scores [61]. The gene discussed is CNR2; the disease is Alzheimer disease.